Detailed Explanation:

Answer: Option 2 — 1 and 2 only

Pneumococcal Conjugate Vaccines (PCVs) are crucial in India's immunization program as they protect against multiple serious diseases caused by Streptococcus pneumoniae and help combat antibiotic resistance. Statement 3 is incorrect as no vaccine is completely free from side effects or allergic reactions.

✅ Statement 1 – Correct: PCVs are highly effective against pneumonia, meningitis (inflammation of brain and spinal cord membranes), and sepsis (blood infection) caused by Streptococcus pneumoniae bacteria.
✅ Statement 2 – Correct: PCVs reduce dependence on antibiotics by preventing pneumococcal infections, thereby addressing the growing problem of antibiotic-resistant bacterial strains.
❌ Statement 3 – Incorrect: Like all vaccines, PCVs can cause mild side effects (redness, swelling, soreness at injection site) and rare allergic reactions; no vaccine is completely side-effect-free.

📝 Short Notes: Pneumococcal Conjugate Vaccines (PCVs)

• Causative Organism: Streptococcus pneumoniae (pneumococcus) — a bacterium with over 90 serotypes.
• Diseases Prevented: Pneumonia, meningitis, sepsis, otitis media (ear infection), and bacteremia.
• Types of Vaccines: PCV10 (protects against 10 serotypes) and PCV13 (protects against 13 serotypes).
• India's Immunization Program: PCV introduced in Universal Immunization Programme (UIP) in 2017; given at 6, 10, and 14 weeks of age.
• Public Health Impact: Reduces child mortality, prevents pneumococcal diseases (leading cause of death in children under 5), and decreases antibiotic use.
• Antibiotic Resistance: PCVs help combat drug-resistant pneumococcal strains by preventing infections, reducing need for antibiotics.
• Common Side Effects: Mild reactions like fever, irritability, injection site reactions; serious allergic reactions are rare but possible.